Altai Protocol Library New Drug: Imlunestrant for ESR1-Mutated Advanced Breast Cancer U. Darda Bayraktar, MD 2025-10-17
Altai Protocol Library New Indication: Amivantamab-Lazertinib for First Line Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-13
Multiple Myeloma New Protocol: Belantamab Mafodotin with Bortezomib/Dexamethasone for R/R Myeloma Ulas D. Bayraktar, MD 2025-09-08
GastroEsophageal Cancer New Protocol: Perioperative Durvalumab with FLOT in Gastric Cancer Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Reference: Neoadjuvant Nivolumab for NSCLC Ulas D. Bayraktar, MD 2025-09-08
Head and Neck Cancer New Indication: Periop Pembrolizumab for Head and Neck Cancer Ulas D. Bayraktar, MD 2025-09-08
Anal Cancer New Reference: Retifanlimab + Chemotherapy for Advanced Anal Cancer Ulas D. Bayraktar, MD 2025-09-08
Multiple Myeloma New Drug: Linvoseltamab for Relapsed/Refractory Myeloma Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Reference: Adagrasib for kRAS Mutated NSCLC Ulas D. Bayraktar, MD 2025-09-08
GastroEsophageal Cancer New Reference: Nivolumab and Ipilimumab for Advanced Gastric Cancer Ulas D. Bayraktar, MD 2025-09-08
